Literature DB >> 17410641

Markedly attenuated acute and chronic pain responses in mice lacking adenylyl cyclase-5.

K-S Kim1, J Kim, S K Back, J-Y Im, H S Na, P-L Han.   

Abstract

Chronic inflammatory and neuropathic pain is often difficult to manage using conventional remedies. The underlying mechanisms and therapeutic strategies required for the management of chronic pain need to be urgently established. The cyclic AMP (cAMP) second messenger system has been implicated in the mechanism of nociception, and the inhibition of the cAMP pathway by blocking the activities of adenylyl cyclase (AC) and protein kinase A has been found to prevent chronic pain in animal models. However, little is known regarding which of the 10 known isoforms of AC are involved in nociceptive pathways. Therefore, we investigated the potential pronociceptive function of AC5 in nociception using recently developed AC5 knockout mice (AC5-/-). We found that AC5-/- mice show markedly attenuated pain-like responses in acute thermal and mechanical pain tests as compared with the wildtype control. Also, AC5-/- mice display hypoalgesic responses to inflammatory pain induced by subcutaneous formalin injection into hindpaws, and to non-inflammatory and inflammatory visceral pain induced by injecting magnesium sulfate or acetic acid into the abdomen. Moreover, AC5-/- mice show strongly suppressed mechanical and thermal allodynia in two nerve injury-induced neuropathic pain models. These results suggest that AC5 is essential for acute and chronic pain, and that AC5 knockout mice provide a useful model for the evaluation of the pathophysiological mechanisms of pain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410641     DOI: 10.1111/j.1601-183x.2006.00238.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  15 in total

1.  Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.

Authors:  Miriam Erdorf; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-29       Impact factor: 3.000

2.  Structure-activity relationships for the interactions of 2'- and 3'-(O)-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases.

Authors:  Cibele Pinto; Gerald H Lushington; Mark Richter; Andreas Gille; Jens Geduhn; Burkhard König; Tung-Chung Mou; Stephen R Sprang; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2011-05-18       Impact factor: 5.858

3.  Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds.

Authors:  Cameron S Brand; Harrison J Hocker; Alemayehu A Gorfe; Claudio N Cavasotto; Carmen W Dessauer
Journal:  J Pharmacol Exp Ther       Date:  2013-09-04       Impact factor: 4.030

4.  Type 5 adenylyl cyclase increases oxidative stress by transcriptional regulation of manganese superoxide dismutase via the SIRT1/FoxO3a pathway.

Authors:  Lo Lai; Lin Yan; Shumin Gao; Che-Lin Hu; Hui Ge; Amy Davidow; Misun Park; Claudio Bravo; Kousaku Iwatsubo; Yoshihiro Ishikawa; Johan Auwerx; David A Sinclair; Stephen F Vatner; Dorothy E Vatner
Journal:  Circulation       Date:  2013-03-27       Impact factor: 29.690

5.  A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion.

Authors:  Claudio A Bravo; Dorothy E Vatner; Ronald Pachon; Jie Zhang; Stephen F Vatner
Journal:  J Pharmacol Exp Ther       Date:  2016-03-03       Impact factor: 4.030

Review 6.  Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies.

Authors:  Rachna Sadana; Carmen W Dessauer
Journal:  Neurosignals       Date:  2008-10-24

Review 7.  Adenylyl cyclase--A-kinase anchoring protein complexes: the next dimension in cAMP signaling.

Authors:  Carmen W Dessauer
Journal:  Mol Pharmacol       Date:  2009-08-14       Impact factor: 4.436

8.  Scaffolding by A-kinase anchoring protein enhances functional coupling between adenylyl cyclase and TRPV1 channel.

Authors:  Riad Efendiev; Alexis Bavencoffe; Hongzhen Hu; Michael X Zhu; Carmen W Dessauer
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

Review 9.  Capturing adenylyl cyclases as potential drug targets.

Authors:  Sandra Pierre; Thomas Eschenhagen; Gerd Geisslinger; Klaus Scholich
Journal:  Nat Rev Drug Discov       Date:  2009-04       Impact factor: 84.694

10.  Persistent Electrical Activity in Primary Nociceptors after Spinal Cord Injury Is Maintained by Scaffolded Adenylyl Cyclase and Protein Kinase A and Is Associated with Altered Adenylyl Cyclase Regulation.

Authors:  Alexis Bavencoffe; Yong Li; Zizhen Wu; Qing Yang; Juan Herrera; Eileen J Kennedy; Edgar T Walters; Carmen W Dessauer
Journal:  J Neurosci       Date:  2016-02-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.